NDC 72572-035

bivalirudin

Bivalirudin

bivalirudin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Civica, Inc.. The primary component is Bivalirudin.

Product ID72572-035_19a4afc5-151d-4d3c-bfef-48aa8797d695
NDC72572-035
Product TypeHuman Prescription Drug
Proprietary Namebivalirudin
Generic NameBivalirudin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-12-21
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA020873
Labeler NameCivica, Inc.
Substance NameBIVALIRUDIN
Active Ingredient Strength250 mg/1
Pharm ClassesAnti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72572-035-10

10 VIAL, SINGLE-USE in 1 CARTON (72572-035-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (72572-035-01)
Marketing Start Date2020-12-21
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "bivalirudin" or generic name "Bivalirudin"

NDCBrand NameGeneric Name
0409-8300BivalirudinBIVALIRUDIN
0781-3158bivalirudinbivalirudin
0781-9158bivalirudinbivalirudin
16729-275BivalirudinBivalirudin
25021-405bivalirudinbivalirudin
52958-034BivalirudinBivalirudin
55111-652BivalirudinBivalirudin
55150-210BIVALIRUDINBIVALIRUDIN
60505-6101Bivalirudinbivalirudin
63323-562BivalirudinBivalirudin
67457-256Bivalirudinbivalirudin
69097-601bivalirudinbivalirudin
70511-141bivalirudinbivalirudin
70860-402BivalirudinBivalirudin
72572-035bivalirudinbivalirudin
71288-427BIVALIRUDINBIVALIRUDIN
0781-3447Angiomaxbivalirudin
65293-001Angiomaxbivalirudin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.